• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Arch Cardiovasc Dis . Cardiopulmonary predictors of mortality in patients with COVID-19: What are the findings?

tetano

Editor, Senior Moderator
Arch Cardiovasc Dis


. 2022 Jun 8;S1875-2136(22)00118-8.
doi: 10.1016/j.acvd.2022.04.008. Online ahead of print.
Cardiopulmonary predictors of mortality in patients with COVID-19: What are the findings?


Hoda Kavosi[SUP] 1 [/SUP], Sepehr Nayebi Rad[SUP] 2 [/SUP], Reza Atef Yekta[SUP] 3 [/SUP], Zahra Tamartash[SUP] 1 [/SUP], Mahboubeh Dini[SUP] 4 [/SUP], Zahra Javadi Nejad[SUP] 1 [/SUP], Leila Aghaghazvini[SUP] 5 [/SUP], Ali Javinani[SUP] 1 [/SUP], Amir Mohammad Mohammadzadegan[SUP] 1 [/SUP], Seyedeh Zahra Fotook Kiaei[SUP] 6 [/SUP]



Affiliations

Abstract

Background: Since 2019, coronavirus disease 2019 (COVID-19) has been the leading cause of mortality worldwide.
Aims: To determine independent predictors of mortality in COVID-19, and identify any associations between pulmonary disease severity and cardiac involvement.
Methods: Clinical, laboratory, electrocardiography and computed tomography (CT) imaging data were collected from 389 consecutive patients with COVID-19. Patients were divided into alive and deceased groups. Independent predictors of mortality were identified. Kaplan-Meier analysis was performed, based on patients having a troponin concentration>99th percentile (cardiac injury) and a CT severity score ≥18.
Results: The mortality rate was 29.3%. Cardiac injury (odds ratio [OR] 2.19, 95% confidence interval [CI] 1.14-4.18; P=0.018), CT score ≥18 (OR 2.24, 95% CI 1.15-4.34; P=0.017), localized ST depression (OR 3.77, 95% CI 1.33-10.67; P=0.012), hemiblocks (OR 3.09, 95% CI 1.47-6.48; P=0.003) and history of leukaemia/lymphoma (OR 3.76, 95% CI 1.37-10.29; P=0.010) were identified as independent predictors of mortality. Additionally, patients with cardiac injury and CT score ≥ 18 were identified to have a significantly shorter survival time (mean 14.21 days, 95% CI 10.45-17.98 days) than all other subgroups. There were no associations between CT severity score and electrocardiogram or cardiac injury in our results.
Conclusions: Our findings suggest that using CT imaging and electrocardiogram characteristics together can provide a better means of predicting mortality in patients with COVID-19. We identified cardiac injury, CT score ≥18, presence of left or right hemiblocks on initial electrocardiogram, localized ST depression and history of haematological malignancies as independent predictors of mortality in patients with COVID-19.

Keywords: Atteinte myocardique; COVID-19; CT score; Cardiac injury; Electrocardiography; Score calcique pulmonaire; Troponin; Électrocardiogramme; Élévation de la troponine.
 
Back
Top Bottom